| ViiV Healthcare GmbH - Dovato, Filmtabletten | | 67313 | | 01 | | Dovato | | Filmtabletten | | J05AR25 | | Lamivudine and Dolutegravir | | 01.05.2020 | | |
| | Composition | | lamivudinum 300 mg, dolutegravirum 50 mg ut dolutegravirum natricum, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, mannitolum, povidonum K 29-32, natrii stearylis fumaras, Überzug: aqua purificata, hypromellosum, macrogolum, E 171, pro compresso obducto corresp. natrium 4.524 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Dolutegravirum | 50 mg | | Lamivudine | 300 mg |
| | BAG: Active Agent | Dose |
|---|
| Dolutegravirum | 50 mg | | Lamivudine | 300 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Aqua Purificata | | Überzug | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | | | Macrogol | | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Stearylis Fumaras | | | | Povidonum K | 29-32 | | | Pro Compresso Obducto | | |
| |
| |
|
